Credit Suisse Ag Dice Therapeutics, Inc. Transaction History

Credit Suisse Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$25.86 - $46.71 $1.11 Million - $2 Million	42,855 Added 162.31%	69,258 $3.22 Million
Q1 2023 May 10, 2023	BUY	$26.05 - $32.31 $208 - $258	8 Added 0.03%	26,403 $756,000
Q4 2022 Feb 13, 2023	BUY	$19.77 - $42.23 $343,978 - $734,759	17,399 Added 193.41%	26,395 $823,000
Q3 2022 Nov 10, 2022	BUY	$14.97 - $22.65 $2,080 - $3,148	139 Added 1.57%	8,996 $181,000
Q2 2022 Aug 12, 2022	BUY	$13.19 - $22.1 $116,823 - $195,739	8,857 New	8,857 $138,000

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.